Rashtriya Newsflash

Posts From admin

Diabetic Retinopathy Market to Expand Rapidly with Advancing Pipeline and Increasing Treatment Adoption by 2036 – DelveInsight | Genentech, Ionis Pharma, AstraZeneca, Regenxbio, AbbVie, Palatin Techn

The Key Diabetic Retinopathy Companies in the market include – Genentech, Ionis Pharmaceuticals, AstraZeneca, Regenxbio, AbbVie, Palatin Technologies, Avirmax Biopharma, Ocular Therapeutix, Inc., MingSight Pharmaceuticals, Inc, OcuTerra Therapeutics, Inc., RemeGen

Read Full Article

EGFR Non Small Cell Lung Cancer Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Astrazeneca, Bridge Biotherapeutics, Sichuan Kelun Pharma

(Albany, New York) – October 07, 2026: As per DelveInsight’s assessment, globally, EGFR Non Small Cell Lung Cancer pipeline constitutes 25+ key companies continuously working towards developing 30+ EGFR Non

Read Full Article

Diabetic Foot Ulcers Market Poised for Sustained Growth Amid Advancements in Treatment and Clinical Innovation – DelveInsight | Topadur Pharma, Cynata Therapeutics, Transwell Biotech, Aposcience

The Key Diabetic Foot Ulcers Companies in the market incldue – Amniox (TissueTech), Topadur Pharma, Cynata Therapeutics, Transwell Biotech, Aposcience, Ilya Pharma, Microbion Corporation, MediWound, Paracrine, INC., NovaLead Pharma, and

Read Full Article

Neuroblastoma Market Analysis 2034: Industry Trends, Market Size, and Emerging Therapeutic Developments – DelveInsight | Y-mAbs Therapeutics, United Therapeutics Corp, EUSA Pharma, Clarity Pharma

The Key Neuroblastoma Companies in the market include – USWM (US WorldMeds), Y-mAbs Therapeutics, United Therapeutics Corporation, EUSA Pharma, Clarity Pharmaceuticals, Eli Lilly, Novartis, Athenex, Aptorum, K C Pharmaceuticals, Novartis,

Read Full Article

Inflammatory Bowel Disease Market Forecast 2036: Rising Demand, Novel Therapies, and Commercial Potential – DelveInsight | AbbVie, Janssen Pharma, Abivax, Morphic Therapeutic, Eli Lilly, Gilead

The Key Inflammatory Bowel Disease Companies in the market include – AbbVie, Janssen Pharmaceuticals, Abivax, Morphic Therapeutic, CJ Bioscience/4D Pharma,

Read Full Article

Degenerative Disc Disease Pipeline 2026: Comprehensive Clinical Trials and Therapies Analysis with Key MOA and ROA Insights by DelveInsight | Mesoblast, DiscGenics, Biosplice Therapeutics, BIOPHARM

(Albany, New York) – October 07, 2026: As per DelveInsight’s assessment, globally, Degenerative Disc Disease pipeline constitutes 15+ key companies

Read Full Article

Chronic Smell and Flavor Loss Market Poised for Sustained Growth Amid Advancements in Treatment and Clinical Innovation – DelveInsight | Cyrano Therapeutics

(Albany, New York) – October 07, 2026: The Key Chronic Smell and Flavor Loss Companies in the market include –

Read Full Article

Cerebral Palsy Market Analysis 2036: Industry Trends, Market Size, and Emerging Therapeutic Developments – DelveInsight | Neurocrine Biosciences, Teva Pharma, Bundang CHA Hospital, Jazz Pharma

(Albany, New York) – October 07, 2026: The Key Cerebral Palsy Companies in the market include – Ipsen, Abbvie (Allergan),

Read Full Article

Focal Segmental Glomerulosclerosis Market to Expand Rapidly with Advancing Pipeline and Increasing Treatment Adoption by 2036 – DelveInsight | Retrophin, AbbVie, AstraZeneca, Pfizer, Sanofi, Teva

(Albany, New York) – October 07, 2026: The Key Focal Segmental Glomerulosclerosis Companies in the market include – Evergreen Therapeutics,

Read Full Article

Alpha Thalassemia Market Forecast 2036: Rising Demand, Novel Therapies, and Commercial Potential – DelveInsight | Forma Therapeutics, Genmedicon Biopharma, Bristol-Myers Squibb, Agios Pharma

(Albany, New York) – October 07, 2026: The Key Alpha Thalassemia Companies in the market include – Forma Therapeutics, Inc.,

Read Full Article